PTX3 and chronic kidney disease: The evaluation of PTX3 levels has been proposed as an important sensitive tool to predict cardiovascular mortality risk in patients with advanced CKD and to identify and treat early-stage subclinical atherosclerosis in these patients5,24,48–50.